Substituted dispensing project rooted on drugs proven of bio equivalencies.

Published: 2006-10-13 06:59:00

Updated: 2006-10-13 06:59:00

Regardless of the recent bio equivalency fraud scandals the future substituted dispensing program via prescriptions in generic drug names should be proceeded with the drugs proven of its bio equivalency as a basic ground, the MOHW indicated in the data to submit for the parliamentary inspection t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK